Carvajal Horacio G, Costello John P, Miller Jacob R, Eghtesady Pirooz, Nath Dilip S
Section of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis/St. Louis Children's Hospital, St. Louis, Missouri.
Division of Pediatric Cardiac Surgery and the Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
J Heart Lung Transplant. 2022 Mar;41(3):271-278. doi: 10.1016/j.healun.2021.12.002. Epub 2021 Dec 16.
Heart-lung transplantation has historically been used as a definitive treatment for children with end-stage cardiopulmonary failure, although the number performed has steadily decreased over time. In this review, we discuss current indications, preoperative risk factors, outcomes, and heart-lung transplantation in unique patient subsets, including infants, children with single-ventricle physiology, tetralogy of Fallot/major aortopulmonary collateral arteries, and prior Potts shunt palliation. We also describe the different surgical techniques utilized in pediatric heart-lung transplantation.
从历史上看，心肺移植一直被用作终末期心肺衰竭儿童的确定性治疗方法，尽管随着时间的推移，其实施数量一直在稳步下降。在本综述中，我们讨论了当前的适应症、术前危险因素、结果以及在特殊患者亚组中的心肺移植情况，这些亚组包括婴儿、单心室生理的儿童、法洛四联症/主要主肺动脉侧支动脉以及既往接受波茨分流姑息手术的患者。我们还描述了小儿心肺移植中使用的不同手术技术。
